Spots Global Cancer Trial Database for recurrent neuroendocrine carcinoma of the skin

Every month we try and update this database with for recurrent neuroendocrine carcinoma of the skin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer	NCT00003549	Neuroendocrine ...	CMF regimen cyclophosphamid... fluorouracil methotrexate	18 Years -	SWOG Cancer Research Network
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	NCT00004922	Carcinoma of Un... Neuroendocrine ... Neuroendocrine ...	irinotecan hydr...	18 Years -	Memorial Sloan Kettering Cancer Center
Oblimersen in Treating Patients With Merkel Cell Carcinoma	NCT00079131	Recurrent Neuro... Stage I Neuroen... Stage II Neuroe... Stage III Neuro... Stage IV Neuroe...	oblimersen sodi... pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	NCT00004922	Carcinoma of Un... Neuroendocrine ... Neuroendocrine ...	irinotecan hydr...	18 Years -	Memorial Sloan Kettering Cancer Center
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors	NCT01155258	Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M...	temsirolimus vinorelbine dit...	18 Years -	University of Southern California
S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer	NCT00068783	Recurrent Neuro... Stage II Neuroe... Stage III Neuro...	imatinib mesyla... laboratory biom...	18 Years -	National Cancer Institute (NCI)
S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer	NCT00003549	Neuroendocrine ...	CMF regimen cyclophosphamid... fluorouracil methotrexate	18 Years -	SWOG Cancer Research Network
Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors	NCT00004922	Carcinoma of Un... Neuroendocrine ... Neuroendocrine ...	irinotecan hydr...	18 Years -	Memorial Sloan Kettering Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: